Compliance Corner: Review Risks When Making Product Or Process Changes, FDA Official Warns

An official with the US Food and Drug Administration is reminding medtech companies that changes they make to medical devices or how they’re made should be closely evaluated to make sure finished products aren’t adversely impacted.

During FDA facility inspections, investigators “often see problems arise when change occurs, and historically, we know that seemingly trivial changes...